Kevin Winthrop
Clinical trials sponsored by Kevin Winthrop, explained in plain language.
-
New hope for rare lung infection: epetraborole trial begins
Disease control Recruiting nowThis study tests a drug called epetraborole for people with a chronic lung infection caused by Mycobacterium abscessus. About 84 adults will take either a low or high dose of the drug or a placebo for 84 days. Researchers will check if symptoms improve and if the infection clears…
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New pill aims to stop hearing loss from lifesaving antibiotics
Prevention Recruiting nowThis study tests whether the drug ORC-13661 can prevent hearing loss in people receiving intravenous amikacin for a lung infection called NTM. About 105 adults will take either a high dose, low dose, or placebo daily for up to 90 days. Researchers will compare hearing changes amo…
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC